Breaking news in spinal cord injury research: FDA approved phase I clinical trial of human, autologous schwann cell transplantation in patients with spinal cord injuries

Files
Breaking News in Spinal Cord Injury Research.pdf (26.45 KB)
If you need an accessible version of this item, please email your request to digschol@iu.edu so that they may create one and provide it to you.
Date
2012-08-05
Authors
Xu, Xiao-Ming
Language
American English
Embargo Lift Date
Department
Department of Neurological Surgery, IU School of Medicine
Committee Members
Degree
Degree Year
Department
Grantor
Journal Title
Journal ISSN
Volume Title
Found At
Wanfang Med Online
Abstract
Description
Keywords
Spinal cord injury, Schwann cells
item.page.description.tableofcontents
item.page.relation.haspart
Cite As
Xu, X.-M. (2012). Breaking News in Spinal Cord Injury Research: FDA Approved Phase I Clinical Trial of Human, Autologous Schwann Cell Transplantation in Patients with Spinal Cord Injuries. Neural Regeneration Research, 7(22), 1685–1687. http://doi.org/10.3969/j.issn.1673-5374.2012.22.001
ISSN
Publisher
Series/Report
Sponsorship
Major
Extent
Identifier
Relation
Journal
Neural Regeneration Research
Rights
Attribution-NonCommercial-NoDerivs 3.0 United States Creative Commons licenses
Source
PMC
Alternative Title
Type
Article
Number
Volume
Conference Dates
Conference Host
Conference Location
Conference Name
Conference Panel
Conference Secretariat Location
Permanent Link
https://hdl.handle.net/1805/10187
DOI
https://doi.org/10.3969/j.issn.1673-5374.2012.22.001
Version
Full Text Available at
This item is under embargo {{howLong}}
Collections
Open Access Policy Articles
Department of Neurological Surgery Works